Allscripts Healthcare Solutions, Inc. (NasdaqGS:MDRX) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its common stock. The company plans to repurchase shares from time to time in the open market or in privately negotiated transactions, subject to market conditions. Under the program, the company could repurchase approximately 18,400,000 additional shares, or approximately 10% of the company's outstanding shares as of October 30, 2016 based on the November 17, 2016 closing price. There is no guarantee as to the exact number of shares or value that will be repurchased under the stock repurchase program. Whether the company makes any repurchases will depend on many factors, including but not limited to its business and financial performance, the business and market conditions at the time, including the price of the company shares, and other factors that management considers relevant. The repurchase program reflects company's ongoing commitment to enhance shareholder value. The company may discontinue purchases at any time. The program will run through December 31, 2019.